FDA Adverse Event Injury Summary report: N

IMPLANTABLE INFUSION PUMP

MDR report key: 5345201 · Received January 5, 2016

Report

Report Number
3007566237-2016-00036
Event Type
Injury
Date Received
January 5, 2016
Report Date
December 12, 2015
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT WAS NOT POSSIBLE TO MATCH THIS EVENT WITH ANY PREVIOUSLY REPORTED EVENT. (B)(4).

Description of Event or Problem · 1

SCANLON, M., BENDEL,M.A., GAZELKA,H.M., HOELZER,B., HOOTEN, M., MOESCHLER,S., LAMER,T.J. SURGICAL SITE INFECTIONS IN CANCER PATIENTS WITH INTRATHECAL DRUG DELIVERY (10272). (B)(6). 2015. 74. SUMMARY: INTRATHECAL DRUG DELIVERY SYSTEMS (IDDS) ARE IMPLANTED IN CANCER PATIENTS PRIMARILY FOR INTRACTABLE PAIN THAT IS REFRACTORY TO MEDICAL MANAGEMENT. CANCER PAIN HAS BEEN SHOWN TO BE SIGNIFICANTLY IMPROVED BY IDDS COMPARED TO MEDICAL THERAPY (REF: SMITH ET AL. ANNALS OF ONCOLOGY 16: 825-833, 2005). THE REPORTED INCIDENCE OF INFECTIOUS COMPLICATIONS FOLLOWING IDDS PLACEMENT VARIES FROM 2 - 8% AND FREQUENTLY REQUIRES PROLONGED ANTIBIOTICS AND DEVICE REMOVAL (REF: ENGLE ET AL. PAIN PHYSICIAN 16: 251-257, 2013). THERE IS LIMITED DATA TO DESCRIBE THE INCIDENCE OF SURGICAL SITE INFECTIONS (SSI) INVOLVING INTRATHECAL PUMP PLACEMENT IN IMMUNOCOMPROMISED CANCER PATIENTS. REPORTED EVENTS: SIXTY-FOUR PATIENTS WERE IDENTIFIED WHO HAD INTRATHECAL PUMPS IMPLANTED BETWEEN THE YEARS 2006 AND 2013. THERE WERE 5 (7.8%) PATIENTS WHO DEVELOPED SURGICAL SITE INFECTIONS. ALL FIVE OF THESE PATIENTS HAD RECEIVED CHEMOTHERAPY OR RADIATION WITHIN 2 MONTHS OF IMPLANTATION. FOUR OF THE 5 WERE ON DEXAMETHASONE. TWO PATIENTS ALSO HAD CONCOMITANT INFECTIONS AT TIME OF IDDS PLACEMENT. FOUR OF THE 5 PATIENTS REQUIRED EXPLANTATION OF THE INTRATHECAL DEVICES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
4724 IMPLANTABLE INFUSION PUMP PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION NEU_UNKNOWN_PUMP UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention